Monthly Oncology Tumor Boards: Optimal Multidisciplinary Management of Advanced Esophageal Cancer
Clinicians must consider disease stage, histology, biomarker expression and patient performance status to make decisions regarding optimal care of patients with esophageal cancer.
Category
  • Gastric/Esophageal Cancer
Format
  • Live Webinar
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • CCM clock hours
  • Participation
Event date October 29, 2021
NCCN Pharmacy Updates: Infection Concerns with Emerging Immune-targeted Treatments in Immunocompromised Patients with Cancer
Although the toxicity profiles of the newer molecularly targeted drugs are less focused on blood cells than those of traditional cytotoxic therapies, there are still infectious risks; safety and efficacy can only be guaranteed by multidisciplinary teams that have therapeutic expertise in the pharmacology of oral anti-cancer therapy.
Category
  • Supportive Care Topics
Format
  • Live Webinar
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Event date November 4, 2021
NCCN Pharmacy Updates: The Evolving Landscape of Maintenance Therapy for Ovarian Cancer
This webinar will discuss key concepts in maintenance therapy for ovarian cancer, review clinical efficacy and safety data on potential treatment options and identify and address special considerations for monitoring and patient/caregiver education.
Category
  • Ovarian Cancer
Format
  • Live Webinar
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Event date November 30, 2021
Monthly Oncology Tumor Boards: Advances in the Management of Gastrointestinal Stromal Tumors (GIST) and Other Soft Tissue Sarcomas
Continued education for oncology care providers is necessary to convey updates in the management of STS and improve patient outcomes.
Category
  • Soft Tissue Sarcomas
Format
  • Live Webinar
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • CCM clock hours
  • Participation
Event date September 21, 2021
Monthly Oncology Tumor Boards: Brain Metastases in Breast Cancer
Clinicians may be challenged when considering a trial of upfront systemic therapy alone for brain metastases, and a multidisciplinary discussion between medical and radiation oncology is recommended.
Category
  • Breast Cancer
Format
  • Live Webinar
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • CCM clock hours
  • Participation
Event date December 9, 2021
Monthly Oncology Tumor Boards: Updates in the Management of Pancreatic Cancer
Continued education regarding the management of pancreatic cancer is required to bridge the gap in cancer care and improve outcomes in the patient population.
Category
  • Pancreatic Cancer
Format
  • Live Webinar
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • CCM clock hours
  • Participation
Event date November 16, 2021
NCCN Pharmacy Updates: Current Challenges with Investigational Drug Services and Expanded Access Programs
It is necessary to identify the practice gaps in investigational drug services and provide solutions for better process improvement in managing clinical trials. In addition, it is important for pharmacists to be familiar with the steps that are involved in initiating expanded access programs and determine the criteria for successful enrollment and implementation of such programs.
Category
Format
  • Live Webinar
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Event date December 16, 2021
Monthly Oncology Tumor Boards: Updates in Management of Renal Cell Carcinoma
Clinicians may find it difficult to determine which single- or multi-agent therapies are most effective for patients with different kidney cancer histologies and risk groups. The NCCN Categories of Preference and Categories of Evidence and Consensus help to stratify the most effective treatment regimens by histology and risk status.
Category
  • Kidney Cancer
Format
  • Live Webinar
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • CCM clock hours
  • Participation
Event date October 20, 2021